Literature DB >> 16111552

The molecular orchestra of the migration of oligodendrocyte precursors during development.

Fernando de Castro1, Ana Bribián.   

Abstract

During development of the central nervous system (CNS), postmitotic cells (including neurons and myelin-generating cells, the oligodendrocytes) migrate from the germinal areas of the neural tube where they originate to their final destination sites. The migration of neurons during development has been extensively studied and has been the topic of detailed reviews. The migration of oligodendrocyte precursor cells (OPCs) is also an extremely complex and precise event, with a widespread migration of OPCs across many regions to colonize the entire CNS. Different mechanisms have been shown to direct the migration of OPCs, among them contact-mediated mechanisms (adhesion molecules) and long-range cues (chemotropic molecules). This review provides a detailed overview and discussion of the cellular and molecular basis of OPCs migration during development. Because it has been shown that neuronal and oligodendroglial lineages share some of these mechanisms, we briefly summarize similarities and differences between these two types of neural cells. We also summarize the changes in the normal migration of OPCs during development that would be relevant for different neurological diseases (including demyelinating diseases, such as multiple sclerosis, and glial cancers). We also examine the relevance of these migratory properties of the oligondendrocytic cell lineage for the repair of neural damage.

Entities:  

Mesh:

Year:  2005        PMID: 16111552     DOI: 10.1016/j.brainresrev.2004.12.034

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  46 in total

1.  Mesenchymal stem cells prime proliferating adult neural progenitors toward an oligodendrocyte fate.

Authors:  Carolin Steffenhagen; Franz-Xaver Dechant; Eleni Oberbauer; Tanja Furtner; Norbert Weidner; Patrick Küry; Ludwig Aigner; Francisco J Rivera
Journal:  Stem Cells Dev       Date:  2011-12-23       Impact factor: 3.272

Review 2.  Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.

Authors:  Davide Lecca; Stefania Ceruti; Marta Fumagalli; Maria P Abbracchio
Journal:  Purinergic Signal       Date:  2012-04-12       Impact factor: 3.765

3.  Voluntary exercise increases oligodendrogenesis in spinal cord.

Authors:  W Krityakiarana; A Espinosa-Jeffrey; C A Ghiani; P M Zhao; N Topaldjikian; F Gomez-Pinilla; M Yamaguchi; N Kotchabhakdi; J de Vellis
Journal:  Int J Neurosci       Date:  2010-04       Impact factor: 2.292

Review 4.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

Review 5.  Oligodendrocyte Development and Plasticity.

Authors:  Dwight E Bergles; William D Richardson
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-20       Impact factor: 10.005

6.  Physiological functions of the small GTPase Arf6 in the nervous system.

Authors:  Masahiro Akiyama; Yasunori Kanaho
Journal:  Small GTPases       Date:  2015-08-20

7.  Cortical Oligodendrocytes in Kaolin-Induced Hydrocephalus in Wistar Rat: Impact of Degree and Duration of Ventriculomegaly.

Authors:  Olugbenga Ayodeji Ayannuga; Thajasvarie Naicker
Journal:  Ann Neurosci       Date:  2017-07-24

Review 8.  Myelin repair strategies: a cellular view.

Authors:  Vittorio Gallo; Regina C Armstrong
Journal:  Curr Opin Neurol       Date:  2008-06       Impact factor: 5.710

9.  Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis.

Authors:  Jessica L Fletcher; Gauthami S Kondagari; Charles H Vite; Peter Williamson; Rosanne M Taylor
Journal:  J Neuropathol Exp Neurol       Date:  2014-06       Impact factor: 3.685

Review 10.  Oligodendrocytes: biology and pathology.

Authors:  Monika Bradl; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2009-10-22       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.